Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jürgen Behr

Showing results (1-10 of 347) with videos related to

Pageof 35
Sort By:
MMW Fortschritte Der Medizin|September 25, 2025
[Pulmonary Fibrosis - early signs and risk factors]Jürgen Behr
The New England Journal of Medicine|August 31, 2012
Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosisJürgen Behr
European Respiratory Review : an Official Journal of the European Respiratory Society|June 4, 2013
Evidence-based treatment strategies in idiopathic pulmonary fibrosisJürgen Behr
MMW Fortschritte Der Medizin|February 22, 2018
[Interstitial lung disease - what the gereneral practitioner should know]Jürgen Behr
American Journal of Respiratory and Critical Care Medicine|July 13, 2017
Disease Progression in Idiopathic Pulmonary Fibrosis. FVC Is Not EnoughJürgen Behr
Clinics in Chest Medicine|February 28, 2012
Approach to the diagnosis of interstitial lung diseaseJürgen Behr
MMW Fortschritte Der Medizin|November 14, 2018
[Pneumology: what are the most important innovations of the decade?]Jürgen Behr
Deutsches Arzteblatt International|February 18, 2014
The diagnosis and treatment of idiopathic pulmonary fibrosisJürgen Behr
American Journal of Respiratory and Critical Care Medicine|September 13, 2023
To Progress or Not to Progress, That Is the Question! Progression in Fibrotic Interstitial Lung DiseaseJürgen Behr
The European Respiratory Journal|May 5, 2023
The art of clinical trial design in pulmonary fibrosisJürgen Behr
Pageof 35

Showing results (1-10 of 347) with videos related to

Sort By:
Pageof 35
MMW Fortschritte Der Medizin|September 25, 2025
[Pulmonary Fibrosis - early signs and risk factors]Jürgen Behr
The New England Journal of Medicine|August 31, 2012
Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosisJürgen Behr
European Respiratory Review : an Official Journal of the European Respiratory Society|June 4, 2013
Evidence-based treatment strategies in idiopathic pulmonary fibrosisJürgen Behr
MMW Fortschritte Der Medizin|February 22, 2018
[Interstitial lung disease - what the gereneral practitioner should know]Jürgen Behr
American Journal of Respiratory and Critical Care Medicine|July 13, 2017
Disease Progression in Idiopathic Pulmonary Fibrosis. FVC Is Not EnoughJürgen Behr
Clinics in Chest Medicine|February 28, 2012
Approach to the diagnosis of interstitial lung diseaseJürgen Behr
MMW Fortschritte Der Medizin|November 14, 2018
[Pneumology: what are the most important innovations of the decade?]Jürgen Behr
Deutsches Arzteblatt International|February 18, 2014
The diagnosis and treatment of idiopathic pulmonary fibrosisJürgen Behr
American Journal of Respiratory and Critical Care Medicine|September 13, 2023
To Progress or Not to Progress, That Is the Question! Progression in Fibrotic Interstitial Lung DiseaseJürgen Behr
The European Respiratory Journal|May 5, 2023
The art of clinical trial design in pulmonary fibrosisJürgen Behr
Pageof 35